Jing Wu

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 33

Top Topics

Cardiovascular Events

Chronic Obstructive Pulmonary Disease

Systematic Review

Top Venues

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Ophthalmology and therapy

Clinical and translational science

International journal of health policy and management

This page only lists publications with an associated author ORCID identifier.

Publications

Weihua Guo, Shitong Xie, Dingyao Wang, Jing Wu
Mapping IWQOL-Lite onto EQ-5D-5L and SF-6Dv2 among overweight and obese population in China. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 33 (3) (2024)
Weihua Guo, Shitong Xie, Dingyao Wang, Jing Wu
Mapping IWQOL-Lite onto EQ-5D-5L and SF-6Dv2 among overweight and obese population in China. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 33 (3) (2024)
Boya Zhao, Jing Wu, Chengzhi Lu, Xing Lin Feng
Generic substitution of amlodipine is not associated with increased risk of mortality or adverse cardiovascular events: An observational cohort study. Clinical and translational science 17 (4) (2024)
Jing Wu, Xiaoning He, Fang Qi, Zhan Zhao, Zhe Xu, Pengcheng Zhang
Efficacy, Safety, and Treatment Burden of Aflibercept 2 mg and Ranibizumab in Retinal Vein Occlusion: A Systematic Review and Meta-analysis. Ophthalmology and therapy (2024)
Boya Zhao, Jing Wu, Chengzhi Lu, Xing Lin Feng
Generic substitution of amlodipine is not associated with increased risk of mortality or adverse cardiovascular events: An observational cohort study. Clinical and translational science 17 (4) (2024)
Jing Wu, Xiaoning He, Fang Qi, Zhan Zhao, Zhe Xu, Pengcheng Zhang
Efficacy, Safety, and Treatment Burden of Aflibercept 2 mg and Ranibizumab in Retinal Vein Occlusion: A Systematic Review and Meta-analysis. Ophthalmology and therapy 13 (5) (2024)
Jing Wu, Xiaoning He, Fang Qi, Zhan Zhao, Zhe Xu, Pengcheng Zhang
Efficacy, Safety, and Treatment Burden of Aflibercept 2 mg and Ranibizumab in Retinal Vein Occlusion: A Systematic Review and Meta-analysis. Ophthalmology and therapy 13 (5) (2024)
Weihua Guo, Shitong Xie, Dingyao Wang, Jing Wu
Mapping IWQOL-Lite onto EQ-5D-5L and SF-6Dv2 among overweight and obese population in China. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2024)
Jing Wu, Xiaoning He, Fang Qi, Zhan Zhao, Zhe Xu, Pengcheng Zhang
Efficacy, Safety, and Treatment Burden of Aflibercept 2 mg and Ranibizumab in Retinal Vein Occlusion: A Systematic Review and Meta-analysis. Ophthalmology and therapy 13 (5) (2024)
Weihua Guo, Shitong Xie, Dingyao Wang, Jing Wu
Mapping IWQOL-Lite onto EQ-5D-5L and SF-6Dv2 among overweight and obese population in China. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 33 (3) (2024)
Boya Zhao, Jing Wu, Chengzhi Lu, Xing Lin Feng
Generic substitution of amlodipine is not associated with increased risk of mortality or adverse cardiovascular events: An observational cohort study. Clinical and translational science 17 (4) (2024)
Shitong Xie, Meixuan Li, Xin Chen, Weihua Guo, Xinran Liu, Kehu Yang, Jing Wu
Health State Utility Values for Children and Adolescents with Type 1 Diabetes: A Systematic Review and Meta-analysis. Diabetic medicine : a journal of the British Diabetic Association (2023)
Boya Zhao, Jing Wu
Impact of China's National Volume-Based Procurement on Drug Procurement Price, Volume, and Expenditure: An Interrupted Time Series Analysis in Tianjin. International journal of health policy and management 12 (2023)
Shanlian Hu, De-Pei Wu, Jing Wu, Yabing Zhang, Mette Bøgelund, Johannes Pöhlmann, Richard F Pollock
Disutilities Associated with Intravenous Iron Infusions: Results from a Time Trade-off Survey and Diminishing Marginal Utility Model for Treatment Attributes in China. Patient related outcome measures 14 (2023)
Boya Zhao, Jing Wu
Impact of China's National Volume-Based Procurement on Drug Procurement Price, Volume, and Expenditure: An Interrupted Time Series Analysis in Tianjin. International journal of health policy and management 12 (2023)
Shitong Xie, Jing Wu, Gang Chen
Comparative performance and mapping algorithms between EQ-5D-5L and SF-6Dv2 among the Chinese general population. The European journal of health economics : HEPAC : health economics in prevention and care (2023)
Boya Zhao, Jing Wu
Impact of China's National Volume-Based Procurement on Drug Procurement Price, Volume, and Expenditure: An Interrupted Time Series Analysis in Tianjin. International journal of health policy and management 12 (2023)
Xinyue Dong, Xiaoning He, Jing Wu
Cost Effectiveness of the First-in-Class ARNI (Sacubitril/Valsartan) for the Treatment of Essential Hypertension in a Chinese Setting. PharmacoEconomics 40 (12) (2022)
Shitong Xie, Jing Wu, Gang Chen
Discrete choice experiment with duration versus time trade-off: a comparison of test-retest reliability of health utility elicitation approaches in SF-6Dv2 valuation. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 31 (9) (2022)
Jia Liu, Xiaoning He, Jing Wu
Economic Evaluation of Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate for the Treatment of Moderate to Very Severe Chronic Obstructive Pulmonary Disease in China Using a Semi-Markov Model. Applied health economics and health policy 20 (5) (2022)
Xinsheng Zhang, Shitong Xie, Feng Xue, Xiaohong Sun, Lingling Chen, Lei Zhang, Jing Wu, Renchi Yang
Health-related quality of life among adults with haemophilia in China: A comparison with age-matched general population. Haemophilia : the official journal of the World Federation of Hemophilia 28 (5) (2022)
Shitong Xie, Jing Wu, Feng Xie
Population Norms for SF-6Dv2 and EQ-5D-5L in China. Applied health economics and health policy 20 (4) (2022)
Yawen Jiang, Jia Liu, Xin Chen, Wenying Yang, Weiping Jia, Jing Wu
Efficacy and Safety of Glucagon-Like Peptide 1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Network Meta-analysis. Advances in therapy 38 (3) (2021)
Tianfu Gao, Jia Liu, Jing Wu
Cost-Effectiveness Analysis of Dabrafenib Plus Trametinib and Vemurafenib as First-Line Treatment in Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma in China. International journal of environmental research and public health 18 (12) (2021)
Chengyu Liu, Jing Wu, Zheng Chang
Trends and Age-Period-Cohort Effects on the Prevalence, Incidence and Mortality of Hepatocellular Carcinoma from 2008 to 2017 in Tianjin, China. International journal of environmental research and public health 18 (11) (2021)
Jing Wu, Shitong Xie, Xiaoning He, Gang Chen, Gengliang Bai, Da Feng, Ming Hu, Jie Jiang, Xiaohui Wang, Hongyan Wu, Qunhong Wu, John E Brazier
Valuation of SF-6Dv2 Health States in China Using Time Trade-off and Discrete-Choice Experiment with a Duration Dimension. PharmacoEconomics 39 (5) (2021)
Jing Wu, Shitong Xie, Xiaoning He, Gang Chen, John E Brazier
The Simplified Chinese version of SF-6Dv2: translation, cross-cultural adaptation and preliminary psychometric testing. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 29 (5) (2020)
Xiaoning He, Yawen Zhang, Yan Zhou, Chaohui Dong, Jing Wu
Direct Medical Costs of Incident Complications in Patients Newly Diagnosed With Type 2 Diabetes in China. Diabetes therapy : research, treatment and education of diabetes and related disorders 12 (1) (2020)
Boya Zhao, Xiaoning He, Jing Wu, Shu Yan
Adherence to statins and its impact on clinical outcomes: a retrospective population-based study in China. BMC cardiovascular disorders 20 (1) (2020)
Weiwei Xu, Jing Wu
International experience with performance-based risk-sharing arrangements: implications for the Chinese innovative pharmaceutical market. International journal of technology assessment in health care 36 (5) (2020)
Fan Yang, Shan Jiang, Xiao-Ning He, Hong-Chao Li, Hong-Yan Wu, Tian-Tian Zhang, Jing Wu
Do Rural Residents in China Understand EQ-5D-5L as Intended? Evidence From a Qualitative Study. PharmacoEconomics - open (2020)
Y Jiang, Weiyi Ni, Jing Wu
Cost-effectiveness and value-based prices of the 9-valent human papillomavirus vaccine for the prevention of cervical cancer in China: an economic modelling analysis. BMJ open 9 (11) (2019)
Xiaoning He, Jing Wu, Anke-Peggy Holtorf, Harald Rinde, Shuangshuang Xie, Wen Shen, Jiancun Hou, Xuehua Li, Ziping Li, Jiaming Lai, Yuting Wang, Lin Zhang, Jian Wang, Xuesong Li, Kuansheng Ma, Feng Ye, Han Ouyang, Hong Zhao
Health economic assessment of Gd-EOB-DTPA MRI versus ECCM-MRI and multi-detector CT for diagnosis of hepatocellular carcinoma in China. PloS one 13 (1) (2018)